Cohesion CoSeal
This article was originally published in The Gray Sheet
Executive Summary
Expansion of the firm's 20-rep U.S. sales force to 25 sales and support staffers is expected by year-end. Cohesion also recently executed contracts with five independent reps in order to meet demand for the surgical sealant. Revenue from CoSeal, approved via PMA in December 2001, has exceeded $1 mil. since its launch in January (1"The Gray Sheet" Dec. 24, 2001, p. 13). The company's Adhibit surgical adhesion prevention gel also has received a CE mark for use in cardiac surgery, and an IDE for a U.S. clinical trial will be filed in early 2003...
You may also be interested in...
Cohesion CoSeal Launch Set For Late January At Thoracic Surgery Meeting
Cohesion Technologies believes that the broad vascular reconstruction indication for its CoSeal surgical sealant makes it less imperative for the firm to pursue site-specific indications immediately
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.